Processa Pharmaceuticals, Inc. (PCSA) has 72 open-market insider trades by 13 insiders since 2020. Over the last six months insiders net bought $135K. The most active filer is Patrick Lin.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| James E. Besser | — | — | 3 | $5.9M | 2021-04-08 |
| David Young | Pres | — | 14 | $485K | 2026-06-30 |
| Justin W. Yorke | Dir | — | 5 | $304K | 2026-06-26 |
| Patrick Lin | — | — | 16 | $274K | 2026-06-30 |
| George K. Ng | CEO | — | 9 | $135K | 2026-08-08 |
| James H. Stanker | CFO | — | 3 | $43K | 2024-07-10 |
| Russell Skibsted | CFO | — | 7 | $42K | 2026-06-30 |
| Wendy Guy | CAO | — | 7 | $33K | 2026-06-30 |
| Sian Bigora | — | — | 4 | $21K | 2026-04-30 |
| Robert Michael Floyd | COO | — | 1 | $14K | 2023-02-09 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| George K. Ng | CEO | Buy | $6K | 2026-07-01 |
| Russell Skibsted | CFO | Buy | $6K | 2026-06-30 |
| Patrick Lin | — | Buy | $4K | 2026-06-30 |
| David Young | President | Buy | $5K | 2026-06-30 |
| Wendy Guy | CAO | Buy | $5K | 2026-06-30 |
| Russell Skibsted | CFO | Buy | $6K | 2026-06-15 |
Companies that share insiders with PCSA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| David Young | President | Buy | $5K | 2026-06-15 |
| George K. Ng | CEO | Buy | $5K | 2026-06-15 |
| Wendy Guy | CAO | Buy | $5K | 2026-06-15 |
| Patrick Lin | — | Buy | $4K | 2026-06-15 |
| Wendy Guy | CAO | Buy | $5K | 2026-05-29 |
| David Young | President | Buy | $5K | 2026-05-29 |
| Patrick Lin | — | Buy | $4K | 2026-05-29 |
| George K. Ng | CEO | Buy | $5K | 2026-05-29 |
| Russell Skibsted | CFO | Buy | $6K | 2026-05-29 |